Tag: device alerts
Empowering Rights: MHRA International Recognition Procedure
Unveiling the MHRA International Recognition Procedure (IRP): The Medicines and Healthcare products Regulatory Agency (MHRA) has launched its groundbreaking new venture.
The MHRA International Recognition Procedure (IRP) marks a significant milestone in regulatory affairs in our view. This new procedure, effective from January 1, 2024, is intended to streamline the recognition of medicines and medical devices, fostering international collaboration and efficiency.
In this article, we take a look at the MHRA’s IRP and how this could tie in with individuals seeking compensation, and how The Group Action Lawyers can guide you through the claims process.
Compensation in a Medical Device Incompatibility Group Action
Medical device incompatibility issues can cause considerable problems for patients and could even lead to harm if something goes wrong.
At The Group Action Lawyers, we understand that when medical devices fail to function as intended, it can lead to serious health risks and complications for patients. In this article, we will delve into the concept of medical device incompatibility and discuss how individuals could be eligible to claim compensation through group actions in some cases. We will also touch on a real example from an alert issued by UK regulators.
Cyberattacks targeting medical devices: a cause for concern?
The idea of cyberattacks targeting medical devices is not so much a theory nowadays, but more of a real cause for concern that needs to be addressed.
As specialist Group Action Lawyers, we are used to seeing the harm caused to real people when things go wrong on a large scale. Whilst we are always here to help, prevention is always better than having to deal with the aftermath. As such, hacks and how they apply to an increasingly digitised world is something that we all need to be wary of; especially when it comes to the healthcare sector.
The priority of protecting consumers from unsafe products
Protecting consumers from unsafe products must always be seen as an absolute priority in the UK and, indeed, around the world.
This is why we were keen to see the results of a recent parliamentary publication. This publication has highlighted a number of flaws and matters to be addressed to ensure that the public is properly protected from harm. We will take a brief look at the headings in terms of the areas of concern, and give our expert take on things.
In terms of action for justice, we remind people that we can represent victims of harm caused by products on a No Win, No Fee basis.
Medoject hypodermic and blunt fill needles
An update has recently been issued by the MHRA (Medicines and Healthcare products Regulatory Agency) warning of the potential dangers of Medoject hypodermic and blunt fill needles produced by the manufacturer. After concerns were raised about certain batches, the manufacturer issued a Field Safety Notice recalling the five batches of needles in question, according to the MHRA. Used by healthcare services across the UK, there is a worry that a potentially harmful substance may have been unknowingly injected into patients.
Over the years, we have taken on a number of claims regarding faulty or harmful medical products, including hernia mesh and metal-on-metal hip implants. One of our biggest group litigation cases is that of the PIP breast implants – in our action, we have already recovered over £1m in compensation for the victims.
Although there is currently no evidence to suggest that anyone has been harmed by the Medoject needles, we believe that all cases like these require thorough investigation.
Medical product compensation claims
We have a huge amount of experience when it comes to representing people for medical product compensation claims on a No Win, No Fee basis.
If you have been harmed and have suffered injury and loss as a result of a medical product, you could be entitled to bring a legal case for damages. These kinds of claims can be hard to succeed with, so it is important that you get the right legal representatives, and experience is key.
It is often the case that you have a fight on your hands when you are taking on huge multinational corporations that manufacture medical devices. We can be your voice for justice to make sure that you receive some form of justice for what you have had to go through.
Pelvic mesh inquiry shows some patients were ignored
The results of the recently published report that follows a large-scale pelvic mesh inquiry raises significant concerns about how women have been treated over this issue.
As the legal representatives for a number of women claiming compensation, the report results did not come as much of a surprise to us. That being said, it was no less worrying to see the results of it.
For some, it may act as some form of vindication. Either way, we represent victims for compensation cases, and if you have yet to look into making a claim, we urge you to speak to our team as soon as you possibly can to avoid missing out.
Ethicon surgical staplers medical device alert
A medical device alert has been issued and published by the MHRA in relation to Ethicon surgical staplers, which have reportedly caused injury to some patients.
It’s understood that there’s a risk that some of the devices manufactured from March 2018 have not been working properly. Reported issues include the devices misfiring or failing to fire the staples during surgery. The MHRA (Medicines and Healthcare products Regulatory Agency) say that there has been increased complaints of malformed stables with some devices being returned.
With this issue involving invasive surgery, the alert is one that needs to be taken incredibly seriously.
Raindrop near vision inlay recall
The Raindrop Near Vision Inlay recall has been initiated due to an increased risk of corneal haze that patients implanted with the devices may experience.
A Medical Device Alert was issued via the MHRA (Medicines and Healthcare products Regulatory Agency) a few weeks ago. There’s a warning to not implant Raindrop Near Vision Inlays and to dispose of any unused stock of them.
Any patients who have already been implanted with the inlays are to be monitored, and any incidents and problems are to be reported. This recall follows the recent news coverage about the Oculentis recall, which is one of the compensation actions we’re representing people for.
Concerns raised over new vaginal mesh guidelines
Following last year’s widespread pause, the new vaginal mesh guidelines have been published. Understandably, concerns have been raised that they may not good enough.
We can tell you from experience that the complications and suffering that women can endure when vaginal mesh surgery goes wrong can be horrendous. We’re acting for women on a No Win, No Fee basis who are making claims for personal injury compensation because of problems they’ve experienced. With some women left unable to work or walk ever again, the continued use of these devices must be heavily scrutinised.
Concerns have been raised that the new vaginal mesh guidelines that have been published haven’t considered the experiences of the victims, and don’t go far enough to protect women who may undergo the procedure.